Isotretinoin and IBD — large real‑world data offer reassurance In one of our recent JDD articles, a retrospective cohort using the TriNetX network compared acne patients exposed to long‑term, low‑dose…
Microdosed Actives Target Dermal Senescence - A Surprising Lab Advance That Could Reshape Dermatoporosis Care Dermatoporosis —age‑related thinning and fragility of the skin driven by fibroblast dysfunction, ECM breakdown, and…
Clascoterone Keeps Gaining Ground in Acne Two identical Phase 3 trials (plus a long‑term extension) randomized patients ≥12 years with moderate‑to‑severe acne to twice‑daily clascoterone 1% cream or vehicle for…
Did You Miss These? Must-Listen JDD Podcasts on Acne, Dyspigmentation & Oncodermatology! Dermatology is always evolving, and if you haven’t caught the latest 'Ask the Investigator' podcast episodes, you’re missing…
Elevate your practice with the very latest clinical insights, case studies, and CME, all in one place. Discover the Acne Resource Center - your new go-to microsite for the very…
Did You Miss These? Missed any of our recent Video Abstracts? Catch up now! A Scientific Approach to Defining, Evaluating, and Treating Pre-Aging With a Cosmetic Regimen Containing a…
Acne Awareness Month: Spotlight on Innovation, Impact, and Individualized Care June is Acne Awareness Month, a timely reminder that acne vulgaris is more than a rite of passage—it’s a complex, chronic…
If Benzoyl Peroxide Disappears: What’s Next for Acne Treatment? Benzoyl peroxide (BPO) has long been a staple in acne therapy—widely used, well-understood, and highly effective. But its future on the…
Mind the Data Gap: Treating Acne-Induced Hyperpigmentation in Deep Skin Tones Acne-induced macular hyperpigmentation (AMH) is a persistent and distressing concern for many patients with richly melanated skin, particularly those…
Could a Migraine Medication Clear Cystic Acne? A Curious Case Suggests New Possibilities What if a drug you prescribe for migraines could also help treat cystic acne? A recent JDD…
GLP-1RAs and Isotretinoin: A Risky Combination? Recent reports on dermatologic side effects of GLP-1 receptor agonists (GLP-1RAs) have prompted a closer look at how these drugs interact with other treatments,…
What Happens After Isotretinoin? New Insights Into Post-Treatment Acne Care Isotretinoin remains the gold standard for treating severe acne, but relapse after treatment is common, affecting 20 to 60% of…